VITROS Immunodiagnostic Products LH Reagent Pack Product Code: 1350198
Recall Z-1113-2022, part of FDA recall event 90047. See Ortho-Clinical Diagnostics's company page.
Ortho-Clinical Diagnostics, Inc started this Class II device recall on Mar 25, 2022 (voluntary: firm initiated); FDA lists it as ongoing.
- Classification: Class II
- Started: Mar 25, 2022
- Status: Ongoing
- Products in this event: 3
Falsely high or delayed patient and QC results may occur due to low end imprecision. VITROS Immunodiagnostic Products FSH, LH and Prol Reagents Low End Imprecision. Low-level quality control (QC) and patient samples at the low end of the Measuring (Reportable) Range when using VITROS FSH, LH and Prol Reagent. Calibration failures, driven by imprecision observed with Calibrator Level 1.
- Product
- VITROS Immunodiagnostic Products LH Reagent Pack Product Code: 1350198
- Quantity
- 1575 units total: 1183 US; 392 OUS
- Lots and codes
- Until further notice, future lots will also be affected. UDI: 10758750008902 Affected Lot Number/ Expiration Date: 1910 14-AUG-2022 1920 19-SEP-2022 1930 19-OCT-2022 1940 31-OCT-2022 1950 28-JAN-2023 1960 31-JAN-2023
- Distribution
- Worldwide Distribution: US (Nationwide) OUS (Foreign): Australia Bermuda Brazil Canada L3R 4G5 Chile China Colombia Denmark France Germany India Italy Japan Mexico Netherlands Norway Portugal Russia Singapore Spain Sweden United Kingdom
- Recalling firm
- Ortho-Clinical Diagnostics, Inc, Raritan, NJ, United States
- How the firm notified
- Letter
- FDA classified
- May 18, 2022
- VITROS Immunodiagnostic Products FSH Reagent Pack- IVD 1931922Z-1112-2022 · Class II · Mar 25, 2022 · Ongoing
- VITROS Immunodiagnostic Products Prolactin Reagent Pack Product Code: 1849793Z-1114-2022 · Class II · Mar 25, 2022 · Ongoing
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports